Skip to main content
Tech.euFundingExplorerBeta

Tilt Biotherapeutics

TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.

Tilt Biotherapeutics has raised €61M across 4 funding rounds from 6 investors, most recently a Series B round in May 2025. Based in Helsinki, Finland; founded 2013; active in Healthtech. Data as of 28 Oct 2026.

Helsinki, FinlandFounded 2013tiltbio.com ↗
Total raised
€61M
€60,935,475
Funding rounds
4
Investors
6
distinct backers
Active since
2020-06
latest 2025-05

Funding by year

EUR raised per year
Tilt Biotherapeutics — funding by year — interactive chart.
Data table
Tilt Biotherapeutics — funding by year
2020€6.2M
2022€10M
2023€22M
2025€22M

Signals

High confidence
Raise-next likelihood69
base rate 48% for Series B
  • ▲ In typical raise window
  • ▼ Low backer re-investment
Exit likelihood22
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 4 rounds raised
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds

Similar companies

same sector or country

Global coverage: FundingData